triamcinolone acetonide

(4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS)-4b-fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one

YNDXUCZADRHECN-JNQJZLCISA-N CHEBI:71418 8 Reactome links 1 studies
1 Observed studies
1 Observed diff profiles
8 Reactome pathways

Metabolite details

Identifier
YNDXUCZADRHECN-JNQJZLCISA-N
IUPAC name
(4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS)-4b-fluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
Preferred name
triamcinolone acetonide
INN name
Synonym
9α-fluoro-11β,21-dihydroxy-16α,17-isopropylidenedioxy-1,4-pregnadiene,3,20-dione
ChEBI
CHEBI:71418

Reactome pathways

Observed in studies

Observed in differential profiles